Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mindbio Therapeutics Corp. ( (TSE:MBIO) ) has issued an update.
MindBio Therapeutics Corp. has announced the completion of its Booze AI software, a groundbreaking voice-activated, AI-powered blood alcohol estimator designed for smartphones and computers. This innovative tool, which stems from clinical trials using MindBio’s proprietary microdose formulation of LSD, aims to educate users about the risks of alcohol consumption and deter drink driving by providing accurate blood alcohol concentration predictions and performance impairment assessments.
More about Mindbio Therapeutics Corp.
MindBio Therapeutics Corp. is a clinical-stage biopharma/biotechnology company focused on developing novel and effective mental health treatments.
Average Trading Volume: 145,376
Technical Sentiment Signal: Sell
Find detailed analytics on MBIO stock on TipRanks’ Stock Analysis page.